CD4+ T cells from HIV-1-infected patients recognize wild-type and mutant human immunodeficiency virus-1 protease epitopes. 2011

N G Muller, and R Alencar, and L Jamal, and J Hammer, and J Sidney, and A Sette, and R M Brindeiro, and J Kalil, and E Cunha-Neto, and S L Moraes
Division of Clinical Immunology and Allergy, Department of Medicine, School of Medicine Heart Institute (InCor) Institute of Tropical Medicine, University of São Paulo, São Paulo, SP 01246-000, Brazil.

Human immunodeficiency virus (HIV)-1 protease is a known target of CD8+ T cell responses, but it is the only HIV-1 protein in which no fully characterized HIV-1 protease CD4 epitopes have been identified to date. We investigated the recognition of HIV-1 protease by CD4+ T cells from 75 HIV-1-infected, protease inhibitor (PI)-treated patients, using the 5,6-carboxyfluorescein diacetate succinimidyl ester-based proliferation assay. In order to identify putative promiscuous CD4+ T cell epitopes, we used the TEPITOPE algorithm to scan the sequence of the HXB2 HIV-1 protease. Protease regions 4-23, 45-64 and 73-95 were identified; 32 sequence variants of the mentioned regions, encoding frequent PI-induced mutations and polymorphisms, were also tested. On average, each peptide bound to five of 15 tested common human leucocyte antigen D-related (HLA-DR) molecules. More than 80% of the patients displayed CD4+ as well as CD8+ T cell recognition of at least one of the protease peptides. All 35 peptides were recognized. The response was not associated with particular HLA-DR or -DQ alleles. Our results thus indicate that protease is a frequent target of CD4+ along with CD8+ proliferative T cell responses by the majority of HIV-1-infected patients under PI therapy. The frequent finding of matching CD4(+) and CD8+ T cell responses to the same peptides may indicate that CD4+ T cells provide cognate T cell help for the maintenance of long-living protease-specific functional CD8+ T cells.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte

Related Publications

N G Muller, and R Alencar, and L Jamal, and J Hammer, and J Sidney, and A Sette, and R M Brindeiro, and J Kalil, and E Cunha-Neto, and S L Moraes
October 2004, Journal of virology,
N G Muller, and R Alencar, and L Jamal, and J Hammer, and J Sidney, and A Sette, and R M Brindeiro, and J Kalil, and E Cunha-Neto, and S L Moraes
January 2014, PloS one,
N G Muller, and R Alencar, and L Jamal, and J Hammer, and J Sidney, and A Sette, and R M Brindeiro, and J Kalil, and E Cunha-Neto, and S L Moraes
August 1997, Journal of immunology (Baltimore, Md. : 1950),
N G Muller, and R Alencar, and L Jamal, and J Hammer, and J Sidney, and A Sette, and R M Brindeiro, and J Kalil, and E Cunha-Neto, and S L Moraes
August 2009, Journal of virology,
N G Muller, and R Alencar, and L Jamal, and J Hammer, and J Sidney, and A Sette, and R M Brindeiro, and J Kalil, and E Cunha-Neto, and S L Moraes
October 2005, Journal of virology,
N G Muller, and R Alencar, and L Jamal, and J Hammer, and J Sidney, and A Sette, and R M Brindeiro, and J Kalil, and E Cunha-Neto, and S L Moraes
June 2004, Journal of virology,
N G Muller, and R Alencar, and L Jamal, and J Hammer, and J Sidney, and A Sette, and R M Brindeiro, and J Kalil, and E Cunha-Neto, and S L Moraes
January 1993, AIDS research and human retroviruses,
N G Muller, and R Alencar, and L Jamal, and J Hammer, and J Sidney, and A Sette, and R M Brindeiro, and J Kalil, and E Cunha-Neto, and S L Moraes
April 2005, Clinical and diagnostic laboratory immunology,
N G Muller, and R Alencar, and L Jamal, and J Hammer, and J Sidney, and A Sette, and R M Brindeiro, and J Kalil, and E Cunha-Neto, and S L Moraes
November 1989, The Journal of clinical investigation,
N G Muller, and R Alencar, and L Jamal, and J Hammer, and J Sidney, and A Sette, and R M Brindeiro, and J Kalil, and E Cunha-Neto, and S L Moraes
June 2019, Pharmaceutics,
Copied contents to your clipboard!